LISATA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
LISATA THERAPEUTICS, INC. (LSTA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$22.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2024-02-29
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$22.00K.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$21.00K.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was $387.00K, a 80.06% decline from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | -$22.00K 10-K · filed 2024-02-29 | |
| 2022-12-31 | -$21.00K 10-K · filed 2024-02-29 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | $1.41M 10-K · filed 2022-03-22 |
| 2020-12-31 | $387.00K 10-K · filed 2022-03-22 | |
| 2019-12-31 | $1.94M 10-K · filed 2021-02-25 | |
| 2018-12-31 | -$1.95M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2013-12-31 | -$3.82M 10-K · filed 2016-03-15 | |
| 2012-12-31 | -$384.80K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |